Latest stories on MDGL
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Business Insider50 · neutralgeneral
Madrigal Pharmaceuticals to Release Second-Quarter 2026 Financial Results and Host Webcast on July 30, 2026
Business Insider50 · neutralearnings
MDGL Stock In Focus — Retail Traders Buzz Over M&A Speculation And Fresh Patents For Liver Drug
Stocktwits News63 · neutralproduct/pr
Madrigal Pharmaceuticals Announces Three New Resmetirom Patents, Strengthening IP Portfolio
Business Insider63 · neutralproduct/pr
BofA lowers its Price Target on Madrigal Pharmaceuticals, Inc. (MDGL)
Yahoo Top48 · neutralanalyst
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH | MDGL Stock News
StockTitan63 · neutralproduct/pr
Ribo and Madrigal Reach First Major Milestone in Advancing Novel siRNA Therapies for MASH
PR Newswire63 · neutralproduct/pr
MADRIGAL PHARMACEUTICALS, INC. (MDGL) files 8-K
SEC 8-K50 · neutralgeneral
Madrigal Pharmaceuticals, Inc. (MDGL) Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026 Transcript
Seeking Alpha55 · neutralgeneral
Madrigal Pharmaceuticals Could Become The Next Vertex
Seeking Alpha56 · neutralanalyst
Madrigal’s Rezdiffra Drives Blockbuster Growth Amid Costs
TipRanks67 · bullishearnings
John Paulson’s fund initiates Amicus Therapeutics position, dumps SOLS among Q1 moves
Seeking Alpha54 · neutralgeneral
Madrigal Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
Yahoo Top50 · neutralearnings
Madrigal’s (MDGL) MASH Strategy Reiinforced By Rezdiffra Sales Growth and Pipeline Expansion
Yahoo Top73 · bullishproduct/pr